Business conference in a hall with white screen

ACC 2017: Late-Breaking Trial Report on Absorb III at 2 Years

Abbott Vascular continues to see challenges in the results of ongoing clinical trials for the Absorb GT1 bioresorbable vascular scaffold (BVS). Two-year outcomes data from ABSORB III were accompanied by an FDA “Dear Healthcare Provider” letter the morning lead investigator Stephen Ellis, M.D., of the Cleveland Clinic, was making his presentation at the American College […]

Read More